Cargando…

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation

Detalles Bibliográficos
Autores principales:	Zou, Dongna, Yu, Haitao, Li, Feifei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087172/ https://www.ncbi.nlm.nih.gov/pubmed/33935746 http://dx.doi.org/10.3389/fphar.2021.647564

Ejemplares similares

Skin Hyperpigmentation in Coronavirus Disease 2019 Patients: Is Polymyxin B the Culprit?
por: Lu, Cuicui, et al.
Publicado: (2020)

Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant Acinetobacter baumannii: A Metabolomic Study
por: Tran, Thien B., et al.
Publicado: (2018)

Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae
por: Yu, Zhenwei, et al.
Publicado: (2022)

Polymyxin B in Patients With Renal Impairment: Is It Necessary to Adjust Dose?
por: Nie, Ruifang, et al.
Publicado: (2022)

Case Report: Respiratory paralysis associated with polymyxin B therapy
por: Ning, Yachan, et al.
Publicado: (2022)

Polymyxin B-Induced Skin Hyperpigmentation
por: Wen, Xueke, et al.
Publicado: (2020)

Population Pharmacokinetics of Polymyxin B and Dosage Optimization in Renal Transplant Patients
por: Li, Ying, et al.
Publicado: (2021)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
por: Chauzy, Alexia, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Based Breakpoints of Polymyxin B for Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Pathogens
por: Bian, Xingchen, et al.
Publicado: (2022)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
por: Wang, Peile, et al.
Publicado: (2021)

Population pharmacokinetic analysis and dosing optimization of polymyxin B in critically ill patients
por: Liang, Danhong, et al.
Publicado: (2023)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study
por: Wu, Zhenping, et al.
Publicado: (2023)

Comparison of Polymyxin E and Polymyxin B as an Additive to Pulmonary Surfactant in Escherichia coli Pneumonia of Ventilated Neonatal Rabbits
por: Stichtenoth, Guido, et al.
Publicado: (2017)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant Pseudomonas aeruginosa
por: Lin, Yu-Wei, et al.
Publicado: (2019)

Visualizing the Potential Impairment of Polymyxin B to Central Nervous System Through MR Susceptibility-Weighted Imaging
por: Zhang, Ni, et al.
Publicado: (2021)

Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes
por: Loutet, Slade A, et al.
Publicado: (2011)

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience
por: Shi, Rupeng, et al.
Publicado: (2023)

Global metabolic analyses identify key differences in metabolite levels between polymyxin-susceptible and polymyxin-resistant Acinetobacter baumannii
por: Mahamad Maifiah, Mohd Hafidz, et al.
Publicado: (2016)

Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats
por: Roy, Dilip, et al.
Publicado: (2021)

Polymyxins: To Combine or Not to Combine?
por: Perez, Federico, et al.
Publicado: (2019)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
por: Jia, Xuedong, et al.
Publicado: (2022)

Research Trends and Collaboration Patterns on Polymyxin Resistance: A Bibliometric Analysis (2010–2019)
por: Quincho-Lopez, Alvaro, et al.
Publicado: (2021)

Precursor Amino Acids Inhibit Polymyxin E Biosynthesis in Paenibacillus polymyxa, Probably by Affecting the Expression of Polymyxin E Biosynthesis-Associated Genes
por: Yu, Zhiliang, et al.
Publicado: (2015)

Polymyxin B-Associated Nephrotoxicity and Its Predictors: A Retrospective Study in Carbapenem-Resistant Gram-Negative Bacterial Infections
por: Wu, Xiao-Li, et al.
Publicado: (2022)

A cyclic adenosine monophosphate response element-binding protein inhibitor enhances the antibacterial activity of polymyxin B by inhibiting the ATP hydrolyzation activity of CrrB
por: Huang, Wei, et al.
Publicado: (2022)

Population pharmacokinetic analysis, renal safety, and dosing optimization of polymyxin B in lung transplant recipients with pneumonia: A prospective study
por: Cai, Xiao-Jun, et al.
Publicado: (2022)

Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant Enterobacteriaceae or Carbapenem-Resistant Acinetobacter baumannii
por: Chang, Kang, et al.
Publicado: (2022)

Evaluation of Activity and Emergence of Resistance of Polymyxin B and ZTI-01 (Fosfomycin for Injection) against KPC-Producing Klebsiella pneumoniae
por: Diep, John K., et al.
Publicado: (2018)

Effect of Different Dosage Frequency of Polymyxin B on Rat Nephrotoxicity
por: Sun, Wenrui, et al.
Publicado: (2021)

Correlation between the drug concentration of polymyxin B and polymyxin B‐associated acute kidney injury in critically ill patients: A prospective study
por: Xu, Ying, et al.
Publicado: (2022)

Interactions of polymyxin B with lipopolysaccharide-containing membranes
por: Goode, Alice, et al.
Publicado: (2021)

Colistin and polymyxin B: A re-emergence
por: Gupta, Sachin, et al.
Publicado: (2009)

Polymyxin B hemoperfusion: a mechanistic perspective
por: Ronco, Claudio, et al.
Publicado: (2014)

Structure-Function Studies of Polymyxin B Lipononapeptides
por: Gallardo-Godoy, Alejandra, et al.
Publicado: (2019)

A Review of the Clinical Pharmacokinetics of Polymyxin B
por: Avedissian, Sean N., et al.
Publicado: (2019)

Polypeptide Self-Assembled Nanoparticles as Delivery Systems for Polymyxins B and E
por: Iudin, Dmitrii, et al.
Publicado: (2020)

Overview of polymyxin resistance in Enterobacteriaceae
por: da Silva, Kesia Esther, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ejqfqmq04h1dc9lvf9i3f15nv